Add BrightSurf on Google Email

How A Common Protein Becomes A Cancer Killer

A new study by University of Wisconsin-Madison biochemist Ron Raines found that a ribonuclease A protein in humans has the same cancer-fighting potential as a frog-derived protein. The finding opens a door to creating a new class of natural drugs aimed at fighting cancer without side effects.

SourceUniversity of Wisconsin-Madison·JournalProceedings of the National Academy of Sciences·DateAug 31, 1998

Scientists Learn How Cells Limit Their Stress

Researchers at Northwestern University have identified a new regulatory molecule, HSBP-1, that regulates the production of heat shock proteins in response to stress. This finding may lead to new insights into cell death associated with aging and diseases such as heart disease and stroke.

SourceNorthwestern University·JournalGenes & Development·DateJul 1, 1998

Jefferson Scientists Hopeful That Understanding Tumor-Suppressor Protein Function May Someday Lead To Treatment

Researchers at Jefferson University have identified a crucial mechanism of the tumor-suppressor protein Fhit, which plays a significant role in preventing cancer development. By understanding how Fhit works, scientists may be able to find ways to interfere with cancer growth and potentially develop new treatments.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateMay 11, 1998

Gene Sequenced For Disabling Childhood Movement Disorder -- Early-Onset Torsion Dystonia Protein Found

Researchers have discovered a new class of proteins that may provide insights into all dystonia disorders. The DYT1 gene codes for torsinA protein, which is mutated in patients with early-onset torsion dystonia, disrupting communication among neurons responsible for movement and muscle control.